FDA perspectives on specs and effective control strategies.
Ruth V. Cordoba-Rodriguez, PhD
Advertisement
Ruth V. Cordoba-Rodriguez, PhD, is a biologist at the division of monoclonal antibodies, Office of Biotechnology Products, Center for Drug Evaluation and Research, US Food and Drug Administration
Articles by Ruth V. Cordoba-Rodriguez, PhD
Advertisement
Latest Updated Articles
Aggregates in MAbs and Recombinant Therapeutic Proteins: A Regulatory PerspectivePublished: November 1st 2008 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
